03-08-2025
ReGen 2025 comes out with guidelines on plasma therapy
The second edition of ReGen 2025, an international conference on regenerative medicine, concluded in Chennai with the release of clinical guidelines for Platelet-Rich Plasma (PRP) therapy.
Developed by a panel of 17 experts, the guidelines aim to standardise PRP procedures widely used in treating sports injuries, orthopaedic conditions and chronic pain by offering evidence-based protocols focused on safety, consent, and follow-up.
G.K. Kumar, organising secretary and head, Department of Anaesthesia and Pain Medicine, Tamil Nadu Government Multi Super Speciality Hospital, said the guidelines fill a critical gap in clinical practice.
Sharmila Tulpule, chairperson of ReGen 2025 and consultant orthopaedic surgeon, said the conference created space for clinical training and international collaboration in a rapidly evolving field.
A. Navaladishankar, co-organising secretary and senior consultant, Apollo Hospital, called the launch a turning point for the country's regenerative medicine ecosystem.
Niteen Tulpule, co-Founder and director, Orthobiologix Biotech Pvt. Ltd., said sessions also focused on emerging therapies such as autologous blood products, donor cell therapy, growth factor applications and bone marrow aspirate concentrate.
A pre-conference hands-on workshop was held on August 1 at the Tamil Nadu Government Multi Super Speciality Hospital.
